Northern Trust Corp Erasca, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Erasca, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,537,949 shares of ERAS stock, worth $4.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,537,949

Previous 853,641 80.16%

Holding current value

$4.11 Million

Previous $2.01 Million 108.44%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.17 - $3.28 $1.48 Million - $2.24 Million	684,308 Added 80.16%	1,537,949 $4.2 Million
Q2 2024 Aug 14, 2024	BUY	$1.79 - $2.63 $342,167 - $502,737	191,155 Added 28.85%	853,641 $2.01 Million
Q1 2024 May 14, 2024	SELL	$1.67 - $2.55 $64,179 - $97,999	-38,431 Reduced 5.48%	662,486 $1.36 Million
Q4 2023 Feb 13, 2024	SELL	$1.67 - $2.49 $28,703 - $42,798	-17,188 Reduced 2.39%	700,917 $1.49 Million
Q3 2023 Nov 13, 2023	BUY	$1.97 - $2.91 $45,993 - $67,939	23,347 Added 3.36%	718,105 $1.41 Million
Q2 2023 Aug 11, 2023	BUY	$2.57 - $3.3 $98,873 - $126,957	38,472 Added 5.86%	694,758 $1.92 Million
Q1 2023 May 15, 2023	BUY	$2.74 - $4.44 $213,799 - $346,448	78,029 Added 13.49%	656,286 $1.98 Million
Q4 2022 Feb 13, 2023	BUY	$3.89 - $8.57 $129,844 - $286,058	33,379 Added 6.13%	578,257 $2.49 Million
Q3 2022 Nov 14, 2022	BUY	$5.82 - $10.68 $368,813 - $676,791	63,370 Added 13.16%	544,878 $4.25 Million
Q2 2022 Aug 12, 2022	BUY	$4.58 - $8.72 $29,206 - $55,607	6,377 Added 1.34%	481,508 $2.68 Million
Q1 2022 May 13, 2022	BUY	$8.6 - $15.48 $2.46 Million - $4.43 Million	286,226 Added 151.52%	475,131 $4.09 Million
Q4 2021 Feb 08, 2022	BUY	$12.51 - $22.75 $77,511 - $140,959	6,196 Added 3.39%	188,905 $2.94 Million
Q3 2021 Nov 15, 2021	BUY	$17.43 - $24.34 $3.18 Million - $4.45 Million	182,709 New	182,709 $3.88 Million

Others Institutions Holding ERAS

# of Institutions

141

Shares Held

229M

Call Options Held

28.7K

Put Options Held

117K

View Full List

About Erasca, Inc.

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $326M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

More about ERAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Erasca, Inc. Transaction History